Principle Investigator

Petra Bizikova

Description

A new trial to investigate a novel monoclonal antibody drug. The goal is to greatly reduce or eliminate the symptoms of this condition thus improving the dog’s quality of life.

Testing Requirements

-Patients will be required to come to NCSU for 8 study visits over the course of 14 weeks.
-Owners will be required to have multiple phone consults on weeks that in clinic visits are not held.
-Owners must closely monitor their dog at home and record in an Owner diary.

Enrollment Start

06/25/2026

Enrollment Finish

06/25/2027

Eligibility

Dogs with moderate to severe non-seasonal Atopic Dermatitis (AD)
Food allergy excluded and/or controlled with an appropriate diet
Current on flea and tick prevention for 12 weeks prior to study and for the duration of the study

Flyer

View

Contact

Dr. Petra Bizikova
pbiziko@ncsu.edu